Amycretin NN9487 : This is a dual agonist (co-agonist) for the GLP-1 receptor and amylin receptor, designed for once-weekly subcutaneous injection or once-daily oral administration
Methods An extensive and systematic literature search was conducted over a 3-month period, from April 2024 to June 2024
These observations suggest that as stringency increased, evolving proteases selected for a P2 aspartic acid preference, a feature present at the observed cleavage sites in both VAMP1 and procaspase-1, but absent in PC_SS1 (Fig
In addition, when produced by tumor cells, as opposed to macrophages or tumor infiltrating macrophages, itaconate enhances the presentation of tumor antigens which, in turn, enhances tumor cell recognition by T cells
This new research was well-done and compelling, but its too early to decide that this molecule, TMAO, causes atherosclerosis in humans or that this is responsible for some of the associations of meat intake and risk. Dr